IL168374A - Vaccines against west nile virus - Google Patents

Vaccines against west nile virus

Info

Publication number
IL168374A
IL168374A IL168374A IL16837405A IL168374A IL 168374 A IL168374 A IL 168374A IL 168374 A IL168374 A IL 168374A IL 16837405 A IL16837405 A IL 16837405A IL 168374 A IL168374 A IL 168374A
Authority
IL
Israel
Prior art keywords
west nile
nile virus
vaccines against
cells
against west
Prior art date
Application number
IL168374A
Other languages
English (en)
Inventor
Alphonsus Gerardus Cornelis Maria Uytdehaag
Govert Johan Schouten
Jaap Goudsmit
Original Assignee
Crucell Holland Bv
Alphonsus Gerardus Cornelis Maria Uytdehaag
Govert Johan Schouten
Jaap Goudsmit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crucell Holland Bv, Alphonsus Gerardus Cornelis Maria Uytdehaag, Govert Johan Schouten, Jaap Goudsmit filed Critical Crucell Holland Bv
Publication of IL168374A publication Critical patent/IL168374A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL168374A 2002-11-08 2005-05-03 Vaccines against west nile virus IL168374A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NLPCT/NL02/00718 2002-11-08
EPPCT/EP03/50129 2003-04-28
PCT/EP2003/050806 WO2004042042A1 (en) 2002-11-08 2003-11-07 Vaccines against west nile virus

Publications (1)

Publication Number Publication Date
IL168374A true IL168374A (en) 2010-11-30

Family

ID=32313778

Family Applications (1)

Application Number Title Priority Date Filing Date
IL168374A IL168374A (en) 2002-11-08 2005-05-03 Vaccines against west nile virus

Country Status (7)

Country Link
AT (1) ATE453708T1 (de)
AU (1) AU2003298277B2 (de)
CA (1) CA2501220C (de)
DE (1) DE60330795D1 (de)
IL (1) IL168374A (de)
NZ (1) NZ538808A (de)
WO (1) WO2004042042A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1583949B1 (de) 2002-10-16 2015-06-17 Gen-Probe Incorporated Zusammensetzungen und verfahren zumnachweis des west-nil-virus
US7927840B2 (en) 2006-09-11 2011-04-19 Gen Probe Incorporated Method for detecting West Nile Virus nucleic acids in the 3′ non-coding region
EP1879921B1 (de) 2005-05-12 2011-04-27 Crucell Holland B.V. Wirtszellenspezifische bindungsmoleküle, die dazu in der lage sind, viren zu neutralisieren, und anwendungen davon
WO2006122964A1 (en) * 2005-05-19 2006-11-23 Crucell Holland B.V. Methods for the production of a whole-inactivated west nile virus vaccine
EP1724338A1 (de) * 2005-05-19 2006-11-22 Crucell Holland B.V. Methode zur Herstellung eines Impfstoffs aus inaktiviertem ganzem Westnilvirus
CN101222936A (zh) * 2005-06-24 2008-07-16 英特威国际有限公司 灭活的嵌合疫苗和相关的使用方法
AU2006271666B2 (en) 2005-07-22 2011-04-07 Crucell Holland B.V. Cell line for producing coronaviruses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1103610A1 (de) * 1999-11-26 2001-05-30 Introgene B.V. Impfstoffherstellung von immortalisierten Säugetierzellinien
WO2002072036A2 (en) * 2001-03-12 2002-09-19 Yale University Compositions and methods comprising west nile virus polypeptides

Also Published As

Publication number Publication date
CA2501220C (en) 2012-01-17
CA2501220A1 (en) 2004-05-21
AU2003298277A1 (en) 2004-06-07
NZ538808A (en) 2008-03-28
AU2003298277B2 (en) 2009-01-22
WO2004042042A1 (en) 2004-05-21
DE60330795D1 (de) 2010-02-11
ATE453708T1 (de) 2010-01-15

Similar Documents

Publication Publication Date Title
IL168374A (en) Vaccines against west nile virus
BR9205771A (pt) Vetor de vírus recombinantes e processo para a fabricaçao do mesmo
MXPA00012402A (es) Metodos y substratos deficientes de interferon, novedosos, para la propagacion de virus.
MX342639B (es) Virus de la influenza recombinantes de alta titulacion para vacunas y terapia genica.
ES8500322A1 (es) Un metodo de modificar un virus para conferirle una nueva funcion biologica.
HUP9802217A2 (hu) Rekombináns MVA-vírus és alkalmazása
DE69928745D1 (de) Uracyl-phosphoribosyltransferase mutante
UA85536C2 (en) Viral antigens
SI1554301T1 (sl) VAKCINA ZA DENGO, KI VSEBUJE SKUPNO DELECIJO 30 NUKLEOTIDOV V 3ĹľUTR TIPOV 1 IN 2 DENGE
DK0604566T3 (da) Kimærisk og/eller vækstbegrænsede flavivirus
MXPA02006888A (es) Flavivirus recombinantes y metodos para utilizar los mismos.
EP1364037A4 (de) Verfahren und zusammensetzungen zur stimulierung einer immunantwort
DK1425404T3 (da) Vaccinia-MVA-E3L-mutanter og anvendelse deraf
CY1106570T1 (el) Σταθερες, εξασθενημενες μεταλλαγμενες μορφες ιου λυσσας και ζωντανια εμβολια αυτων
SG169325A1 (en) Promoters for expression in modified vaccinia virus ankara
MXPA02012593A (es) Particulas de tipo virus del virus de la diarrea viral bovina.
IL146191A0 (en) Viral expression vectors
GB2409681A (en) Nucleic acid constructs for gene expression
WO2002038769A3 (de) Für expression in eukaryonten optimierte hpv 16-l1 und hpv 16-l2 kodierende dna-sequenzen
NO20005482D0 (no) Rekombinant virus som uttrykker fremmed DNA som koder for Felin CD80, Felin CTLA-4 eller Felin CD86 og anvendelse derav
HUP0103871A2 (hu) Rekombináns CELO-vírus és CELO vírus DNS
PT1383796E (pt) Estirpe neurovirulenta do vírus do nilo ocidental e as suas aplicações
WO2004056979A3 (en) Recombinant virus production for the manufacturing of vaccines
WO2002078621A3 (en) Replication-competent recombinant virus and methods of use thereof

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed